Twist Bioscience (TWST) Inventory (2018 - 2026)

Twist Bioscience has disclosed Inventory across 9 years of filings, most recently posting $33.5 million for Q1 2026.

• In Q1 2026, Inventory rose 60.67% year-over-year to $33.5 million; the TTM figure through Mar 2026 stood at $33.5 million (up 60.67% YoY), while the FY2025 annual figure was $28.3 million, up 17.57% from the prior year.
• Inventory advanced to $33.5 million in Q1 2026, from $32.9 million in the prior quarter.
• Over the last five years, Inventory for TWST reached as high as $44.6 million in Q4 2022 and fell as low as $20.9 million in Q1 2025.
• The 5-year median for Inventory is $32.1 million (2023), against an average of $32.9 million.
• Annual changes were most pronounced in 2022 — Inventory jumped 181.54% — and 2025, when it sank 31.33%.
• A 5-year view of Inventory shows it stood at $44.6 million in 2022, then sank by 30.8% to $30.9 million in 2023, then decreased by 23.8% to $23.5 million in 2024, then soared by 39.99% to $32.9 million in 2025, then gained by 1.8% to $33.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $33.5 million, $32.9 million, and $28.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.